Cite

HARVARD Citation

    Elkins, J. et al. (n.d.). Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet neurology. 16 (3), pp. 217-226. [Online]. 
  
Back to record